Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction.

ABSTRACT:

SUBMITTER: Zheng YZ 

PROVIDER: S-EPMC10028314 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature